International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: http://www.sciepub.com/journal/ijcd Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
Go
International Journal of Celiac Disease. 2017, 5(3), 108-110
DOI: 10.12691/ijcd-5-3-8
Open AccessArticle

Celiac Disease and Cancers in Morocco

Ayoub Aomari1, , Mohamed Firwana1, Imank Benelbarhdadi1 and FZ. Ajana1

1Department of Gastroenterology and liver diseases, medicine C, IBN SINA University hospital, Rabat, Morocco

Pub. Date: August 08, 2017

Cite this paper:
Ayoub Aomari, Mohamed Firwana, Imank Benelbarhdadi and FZ. Ajana. Celiac Disease and Cancers in Morocco. International Journal of Celiac Disease. 2017; 5(3):108-110. doi: 10.12691/ijcd-5-3-8

Abstract

Digestive cancers are the most severe complications of celiac disease (CD), which can lead to death. We can report 12 patients with CD associated with cancer. It is retrospective study of 12 patients with CD complicated by cancers, collected in the department of diseases of the digestive system "Medicine C", from 1995 to 2017. Six patients had lymphoma, three were gastric tumors, two were small intestine tumors, and one had liver tumor. The diagnosis of lymphoma was made at the same time as that of CD in one patient, three months later in two patients, 18 months later in two patients and 8 years later in one patient. Morphological and histological data were in favor of malignant non-Hodgkin's lymphoma with intestinal localization in four patients, with lymph node localization in one patient and one patient with refractory celiac disease type 2 with intraepithelial lymphoma. The treatment consisted of chemotherapy in four patients and corticosteroid therapy with parenteral nutrition in one patient. The evolution was marked by the death of 03 patients and 2 patients were lost without any idea about their evolution. The diagnosis of the gastric tumor was retained after the realization of a upper gastrointestinal endoscopy with biopsies. The histopathologic examination was in favor of a well-differentiated adenocarcinoma in two patients, and of an adenocarcinoma moderately differentiated in one patient. The diagnosis of the well-differentiated neuroendocrine tumor was carried out 30 years after that of CD. The patient underwent a resection of the first two duodenal portions with duodeno-jejunal anastomosis and a colonic resection with termino-terminal anastomosis. The evolution was good with a 2 years follow-up. The second patient with intestinal cancer was a moderately differentiated adenocarcinoma of intestinal origin; the diagnosis was retained after an abdominal CT scan with mass biopsy. The treatment was palliative chemotherapy, with an abdominal scan three months later showed partial response. The hepatocellular carcinoma on healthy liver was diagnosed at the same time as CD on angio-CT scan data and liver biopsy with patient death at the time of diagnosis. Digestive cancers are severe complications of CD requiring early management and follow-up of patients to reduce the rate of death.

Keywords:
cancers celiac disease

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Samasca G, Lupan I, Deleanu D, Cristea V, Makovicky P. Immunological approach of the challenges of the XXI century in celiac disease. Int Rev Immunol 2014; 33(1): 3-8.
 
[2]  Holmes GK, Stokes PL, Sorahan TM, Prior P, Waterhouse JA, Cooke WT. Coeliac disease, gluten-free diet, and malignancy. Gut. 1976;17:612-619.
 
[3]  Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005;128:S79-S86.
 
[4]  Brousse N, Meijer JW. Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol. 2005;19:401-412.
 
[5]  Freeman HJ, Weinstein WM, Shnitka TK, Piercey JR, Wensel RH. Primary abdominal lymphoma. Presenting manifestation of celiac sprue or complicating dermatitis herpetiformis. Am J Med. 1977;63:585-594.
 
[6]  Freeman HJ, Chiu BK. Multifocal small bowel lymphoma and latent celiac sprue. Gastroenterology. 1986;90:1992–1997
 
[7]  Freeman HJ. Occult celiac disease in an octogenarian presenting with a small intestinal adenocarcinoma. Can J Gastroenterol. 1994;8:354-357.
 
[8]  Freeman HJ, Chiu BK. Small bowel malignant lymphoma complicating celiac sprue and the mesenteric lymph node cavitation syndrome. Gastroenterology. 1986;90:2008-2012.
 
[9]  Freeman HJ. Neoplastic disorders in 100 patients with adult celiac disease. Can J Gastroenterol. 1996;10:163-166.
 
[10]  Freeman HJ. Lymphoproliferative and intestinal malignancies in 214 patients with biopsy-defined celiac disease. J Clin Gastroenterol. 2004;38:429-434.
 
[11]  Isaacson PG, O'Connor NT, Spencer J, Bevan DH, Connolly CE, Kirkham N, et al. Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet. 1985;2:688-691.
 
[12]  Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol. 2005;19:413-424.
 
[13]  Verkarre V, Romana SP, Cellier C, Asnafi V, Mention JJ, Barbe U, et al. Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. Gastroenterology. 2003; 125:40-46
 
[14]  Cellier C, Delabesse E, Helmer C, Patey N, Matuchansky C, Jabri B,et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet. 2000;356:203-208.
 
[15]  Mearin ML, Catassi C, Brousse N, Brand R, Collin P, Fabiani E, et al. European multi-centre study on coeliac disease and non-Hodgkin lymphoma. Eur J Gastroenterol Hepatol. 2006;18: 187-194.
 
[16]  Rampertab SD, Fleischauer A, Neugut AI. Green PH. Risk of duodenal adenoma in celiac disease. Scand J Gastroenterol. 2003;38:831-833.
 
[17]  Howdle PD, Jalal PK, Holmes GK, Houlston RS. Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM. 2003;96:345-353.
 
[18]  Ciccocioppo R, Perfetti V, Corazza GR. Treating ETTCL: A matter of early diagnosis and chemotherapy strategies. Dig Liver Dis. 2007;39:642-645.